Bodisen Biotech (FRA:DZ9) Change In Payables And Accrued Expense : €0.03 Mil (TTM As of Jun. 2013)

View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Change In Payables And Accrued Expense?

Bodisen Biotech's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2013 was €0.28 Mil. It means Bodisen Biotech's Accounts Payable & Accrued Expense increased by €0.28 Mil from Dec. 2012 to Jun. 2013 .

Bodisen Biotech's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2012 was €0.01 Mil. It means Bodisen Biotech's Accounts Payable & Accrued Expense increased by €0.01 Mil from Dec. 2011 to Dec. 2012 .

Bodisen Biotech Change In Payables And Accrued Expense Historical Data

The historical data trend for Bodisen Biotech's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Change In Payables And Accrued Expense Chart

Bodisen Biotech Annual Data

Trend

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

-0.48

-0.40

1.35

-1.02

0.01

Bodisen Biotech Quarterly Data
	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Jun13
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.04	0.31	0.18	-0.42	0.28

Bodisen Biotech Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03 Mil.

Bodisen Biotech Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Bodisen Biotech (FRA:DZ9) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Bodisen Biotech Inc (FRA:DZ9) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.bodisen.com

Bodisen Biotech Inc develops, manufactures and sells organic fertilizers, liquid fertilizers, pesticides and insecticides in China.

Bodisen Biotech (FRA:DZ9) Headlines

No Headlines